Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines

Respiratory syncytial virus (RSV) is responsible for a significant proportion of global morbidity and mortality affecting young children and older adults. In the aftermath of formalin-inactivated RSV vaccine development, the effort to develop an immunizing agent was carefully guided by epidemiologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Topalidou, Xanthippi, Kalergis, Alexis M., Papazisis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609699/
https://www.ncbi.nlm.nih.gov/pubmed/37887775
http://dx.doi.org/10.3390/pathogens12101259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609699/
https://www.ncbi.nlm.nih.gov/pubmed/37887775
http://dx.doi.org/10.3390/pathogens12101259

Ejemplares similares